MarieHuMD

Hematology/Oncology

Hematology-Oncology Fellow at University of Minnesota

Dr. Hu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of MinnesotaFellowship, Hematology and Medical Oncology, 2019 - 2022
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2016 - 2019
Ohio State University College of MedicineClass of 2016, MD
Massachusetts Institute of TechnologyBS, Biology, 2008 - 2012

PubMed

6 citations
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma.
Nausheen Ahmed, William Wesson, Muhammad Umair Mushtaq, David L Porter, Sunita D Nasta
Transplantation and Cellular Therapy. 2023-07-01
18 citations
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis
Gaurav Goyal, Jithma P. Abeykoon, Marie Hu, Jason R. Young, Mithun Vinod Shah
American Journal of Hematology. 2021-05-01
12 citations
Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: staging, natural history, and comparative survival.
Antonious Z. Hazim, Gordon Ruan, Marie Hu, Aishwarya Ravindran, Karen L. Rech
American Journal of Hematology. 2021-10-08

Abstracts/Posters

Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis
Marie Hu, Gaurav Goyal, et al, 61st Annual American Society of Hematology Meeting, 12/7/2019
Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
Gaurav Goyal, Marie Hu, et al, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019